Oats
Umbhali:
Virginia Floyd
Umhla Wokudalwa:
7 Eyethupha 2021
Hlaziya Umhla:
16 Eyenkanga 2024
Umxholo
- Kusenokwenzeka ukuba iyasebenza ...
- Inokwenzeka ukuba isebenze ...
- Kusenokwenzeka ukuba ayisebenzi ...
- Akukho bungqina baneleyo bokulinganisa ukusebenza ...
- Amanyathelo okhuseleko kunye nezilumkiso:
I-oat bran kunye ne-oats iphela zisetyenziselwa isifo sentliziyo kunye ne-cholesterol ephezulu. Zikwasetyenziselwa uxinzelelo lwegazi oluphezulu, isifo seswekile, umhlaza, ulusu olomileyo, kunye nezinye iimeko ezininzi, kodwa abukho ubungqina benzululwazi obuxhasa ezi zinto zisetyenziswayo.
Amayeza endalo aVimba weDatha Ukusebenza kwexabiso ngokusekwe kubungqina besayensi ngokwala manqanaba alandelayo: Ukusebenza, ukusebenza ngokukuko, okunokwenzeka ukuba kusebenze, okungenzeka kungasebenzi, kunokwenzeka ukungasebenzi, ukungasebenzi, kunye nobungqina obungonelanga bokulinganisa.
Ukulinganiswa kokusebenza kwe IIMPAWU zezi zilandelayo:
Kusenokwenzeka ukuba iyasebenza ...
- Isifo sentliziyo. Iimveliso ze-Oat ziqulathe isixa esikhulu sefayibha. Ukutya okuphezulu kwifayibha enyibilikayo kunokusetyenziswa njengenxalenye yokutya okunamafutha asezantsi, ukutya okune-cholesterol encinci ukuthintela isifo sentliziyo. Uphando lubonisa ukuba umntu kufuneka atye ubuncinci i-3.6 gram yefayibha enyibilikayo yonke imihla ukunciphisa umngcipheko wesifo sentliziyo.
- Cholesterol ephezulu. Ukutya i-oats, i-oat bran, kunye nezinye iifayibha ezinokunyibilika zinokunciphisa ngokuthobekileyo i-cholesterol "engalunganga" ye-lipoprotein (LDL) xa isetyenziswa njengenxalenye yokutya okunamafutha amaninzi. Kwigram nganye yefayibha enyibilikayo (i-beta-glucan) esetyenzisiweyo, iyonke i-cholesterol iyancipha malunga ne-1.42 mg / dL kunye ne-LDL malunga ne-1.23 mg / dL. Ukutya i-3-10 iigremu zefayibha enyibilikayo kunokunciphisa i-cholesterol iyonke malunga ne-4-14 mg / dL. Kodwa kukho umda. Imilinganiselo yefayibha enyibilikayo engaphezulu kwe-10 gram ngemini ayibonakali inyusa ukusebenza.
Ukutya izitya ezintathu ze-oatmeal (i-28 gram servings) yonke imihla kunokunciphisa i-cholesterol iyonke malunga ne-5 mg / dL. Iimveliso ze-oat bran (i-oat bran muffins, i-oat bran flakes, i-oat bran Os, njl.njl.) Zinokwahluka ngokwazi kwazo ukunciphisa i-cholesterol, kuxhomekeke kumxholo wefayibha yonke enyibilikayo. Iimveliso ze-oat zizonke zinokusebenza ngakumbi ekwehliseni i-LDL kunye ne-cholesterol iyonke kunokutya okune-oat bran kunye ne-beta-glucan soluble fiber.
I-FDA icebisa ukuba malunga ne-3 gram yefayibha enyibilikayo ithathwe yonke imihla ukuthoba amanqanaba e-cholesterol egazini. Nangona kunjalo, le ngcebiso ayihambelani neziphumo zophando; Ngokwezifundo zeklinikhi ezilawulwayo, ubuncinci i-3.6 iigram zefayibha enyibilikayo yonke imihla iyafuneka ukunciphisa i-cholesterol.
Inokwenzeka ukuba isebenze ...
- Seswekile. Ukutya i-oats kunye ne-oat bran kwiiveki ezi-4-8 kunciphisa ngaphambi kokutya iswekile yegazi, iiyure ezingama-24 zeswekile yegazi, kunye namanqanaba e-insulin kubantu abane-2 yeswekile. Ukutya i-50-100 gram ye-oats endaweni yezinye iicarbohydrate kunciphisa emva kokutya iswekile yegazi kwabanye abantu. Ixesha elide, ukutya i-100 gram ye-oats endaweni yezinye i-carbohydrate kunesiphumo esona sihlala ixesha elide kwiglucose yegazi. Ukutya i-oats kunokunceda ukunciphisa amanqanaba e-cholesterol kubantu abanesifo seswekile.
- Umhlaza wesisu. Abantu abatya ukutya okunefayibha ephezulu, njenge-oats kunye ne-oat bran, babonakala benomngcipheko ophantsi womhlaza wesisu.
Kusenokwenzeka ukuba ayisebenzi ...
- Umhlaza wekolon, umhlaza we-rectal. Abantu abadla i-oat bran okanye i-oats ababonakali benomngcipheko omncinci womhlaza wekolon. Kwakhona, ukutya i-oat bran fiber ayihambelani nomngcipheko omncinci wokuphindaphinda kwe-colon tumor.
- Igazi elonyukayo. Ukutya i-oats njenge-oatmeal okanye i-oat cereal ayinciphisi uxinzelelo lwegazi kumadoda anexinzelelo lwegazi.
Akukho bungqina baneleyo bokulinganisa ukusebenza ...
- I-eczema (i-atopic dermatitis). Uphando lwakwangoko lubonisa ukuba ukusebenzisa ukhilimu oqukethe ii-oats ze-colloidal kunokunceda ukunciphisa iimpawu zokhwekhwe. Kubantu abasebenzisa ioyile equkethe i-steroid ebizwa ngokuba yi-fluocinolone ukunciphisa iimpawu zeczema, ukusebenzisa ukhilimu oqukethe ii-colloidal oats kunceda ukugcina nasiphi na isibonelelo.
- Umhlaza webele. Ukutya ii-oats ezininzi ngaphambi kokuba kufunyaniswe ukuba unesifo somhlaza webele kunokunceda abasetyhini abanomhlaza wamabele baphile ixesha elide.
- Imemori kunye nezakhono zokucinga (umsebenzi wokuqonda). Uphando lwakwangoko lubonisa ukuba ukuthatha isicatshulwa esithile se-oats eluhlaza (i-Neuravena) kunokuphucula isantya sokusebenza kwengqondo kubantu abadala abasempilweni.
- Ulusu olomileyo. Sebenzisa into yokuthambisa ene-colloidal oat extract kubonakala kuphucula ulusu olomileyo.
- Ubuhlungu bemisipha obubangelwa kukuzilolonga. Uphando lwakwangoko lubonisa ukuba ukutya ii-cookies ezinomgubo we-oat kunokunceda ukunciphisa ukukhathazeka kwezihlunu kwiintsuku ezisemveni kokuzilolonga.
- Utshintsho kwindlela amafutha asasazwa ngayo emzimbeni kubantu abathatha amayeza e-HIV. Ukutya ukutya okunesinga eliphezulu, kubandakanya i-oats, ene-eneji eyaneleyo kunye neeproteni kunokuthintela ukuqokelelana kwamafutha kubantu abane-HIV. Ukonyuka kwe-gram kwi-fiber yokutya iyonke kunokunciphisa umngcipheko wokuqokelelwa kwamafutha nge-7%.
- Ukuhlelwa kweempawu ezonyusa umngcipheko wesifo seswekile, isifo sentliziyo, kunye nokubetha (isifo se-metabolic syndrome). Uphando lwakwangoko lubonisa ukuba ukongeza i-oats kwisidlo esezantsi sekhalori akubonakali ngathi kunaso nasiphi na isibonelelo esongezelelweyo ekunciphiseni ubunzima, amafutha egazini, uxinzelelo lwegazi, okanye iswekile yegazi kubantu abane-metabolic syndrome.
- Ukurhawuzelela. Uphando lwakwangoko lubonisa ukuba ukusebenzisa into yokuthambisa ene-oats kunciphisa ukurhawuzelela ulusu kubantu abanesifo sezintso. I-lotion ibonakala isebenza kunye nokuthatha i-antihistamine hydroxyzine 10 mg.
- Ukubetha. Ukutya i-oats kanye ngeveki endaweni yamaqanda okanye isonka esimhlophe kunokunceda ukuthintela ukubetha.
- Uhlobo lwesifo sokukrala kwamathumbu (ulcerative colitis). Uphando lwakwangoko lubonisa ukuba ukuthatha imveliso ethile esekwe kwi-oat (Profermin) ngomlomo kunokunciphisa iimpawu kunye nokuthintela ukuphindaphinda kwesifo sezilonda.
- Ixhala.
- Ukuphulukana nolawulo lwesinyi (ukungabikho komchamo).
- Ukuqunjelwa.
- Urhudo.
- Ukuphambuka.
- Igawuthi.
- Ingxaki yexesha elide yamathumbu amakhulu ebangela iintlungu zesisu (isifo esiswini esinokucaphuka okanye i-IBS).
- Isifo samathambo (RA).
- Osteoarthritis.
- Ukudinwa.
- Ukudinwa okungapheliyo (i-CFS).
- Ukurhoxa kwi-heroin, morphine, kunye nezinye iziyobisi ze-opioid.
- Isifo senyongo.
- Umkhuhlane (umkhuhlane).
- Khohlela.
- Umqwebedu.
- Ukuphilisa amanxeba.
- Rough, isikhumba esinamaxolo esikhumbeni nasebusweni (seborrheic dermatitis).
- Amabala.
- Ukutsha.
- Ezinye iimeko.
I-Oats inokunceda ukunciphisa i-cholesterol kunye namanqanaba eswekile yegazi kunye nolawulo lokutya ngokubangela ukuziva uzele. I-oat bran inokusebenza ngokuthintela ukufunxwa emathunjini ezinto ezinegalelo kwisifo sentliziyo, i-cholesterol ephezulu kunye nesifo seswekile. Xa isetyenziswa kulusu, ii-oats zibonakala ngathi zinciphisa ukudumba.
Xa kuthathwa ngomlomo: I-oat bran kunye ne-oats epheleleyo NGOKUKHUSELEKILEYO kubantu abaninzi xa isetyenziswa kwisixa esifumaneka ekutyeni. I-oats inokubangela irhasi yamathumbu kunye nokuqunjelwa. Ukunciphisa iziphumo ebezingalindelekanga, qala ngedosi esezantsi kwaye unyuse kancinci ukuya kwisixa osifunayo. Umzimba wakho uya kusetyenziselwa i-oat bran kunye nemiphumo emibi iya kuhamba.
Xa isetyenziswa eluswiniI-Lotion equkethe i-oat extract UKHUSELEKO OLUNOKWENZEKA ukusebenzisa kulusu. Ukubeka iimveliso eziqukethe i-oat esikhumbeni kunokubangela ukuba abanye abantu babe ne-rash.
Amanyathelo okhuseleko kunye nezilumkiso:
Ukukhulelwa kunye nokuncancisa: I-oat bran kunye ne-oats epheleleyo NGOKUKHUSELEKILEYO xa ungeniswe ngabafazi abakhulelweyo nabancancisayo kwixabiso elifumaneka kukutya.Isifo seCeliacAbantu abanesifo se-celiac akufuneki batye i-gluten. Abantu abaninzi abanesifo se-celiac baxelelwa ukuba bakuphephe ukutya ii-oats kuba zinokungcoliswa yingqolowa, irye, okanye irhasi, ene-gluten. Nangona kunjalo, kubantu abangenazo iimpawu ubuncinci iinyanga ezi-6, ukutya amanani alinganisiweyo e-oats emsulwa, engangcolisekanga kubonakala kukhuselekile.
Ukuphazamiseka kwendlela yokugaya ukutya kubandakanya isisu, isisu kunye namathumbu: Kuphephe ukutya iimveliso ze-oat. Iingxaki zokugaya ukutya ezinokwandisa ubude bexesha elithathwayo ekutyeni kokutya kwakho zinokuvumela i-oats ukuba ibambe amathumbu akho.
- Iphakathi
- Lumka ngale nhlanganisela.
- I-insulin
- I-Oats inokunciphisa inani le-insulin efunekayo ukulawula iswekile yegazi kubantu abane-2 yeswekile. Ukuthatha i-oats kunye ne-insulin kunokubangela ukuba iswekile esegazini lakho ibe sezantsi kakhulu. Jonga eswekile yegazi lakho ngokusondeleyo. Umthamo we-insulin yakho unokufuna ukuba utshintshwe.
- Amayeza eswekile (iziyobisi zeAntidiabetes)
- I-oats inokunciphisa iswekile yegazi. Amayeza eswekile asetyenziselwa ukunciphisa iswekile yegazi. Ukuthatha i-oats kunye namayeza eswekile kunokubangela ukuba iswekile egazini lakho lihle kakhulu. Jonga eswekile yegazi lakho ngokusondeleyo. Umthamo weyeza lakho leswekile unokufuna ukuba utshintshwe.
Amanye amayeza asetyenziselwa isifo seswekile aquka i-glimepiride (Amaryl), i-glyburide (i-DiaBeta, i-Glynase PresTab, i-Micronase), i-insulin, i-pioglitazone (i-Actos), i-rosiglitazone (i-Avandia), i-chlorpropamide (i-Diabinese), i-glipizide (i-Glucotrol), i-tolbutamide (i-Orinase), .
- Iherbs kunye nezongezo ezinokunciphisa iswekile yegazi
- I-Oats inokunciphisa amanqanaba eswekile yegazi. Ukuyisebenzisa ngamanye amayeza okanye izongezo ezinesiphumo esifanayo kunokunciphisa amanqanaba eswekile yegazi kakhulu. Kulumkele ukudibanisa. Eminye imifuno enokuthi yehlise iswekile yegazi yi-devil's claw, i-fenugreek, igalikhi, i-guar gum, i-chestnut yehashe, i-Panax ginseng, i-psyllium, kunye ne-ginseng yaseSiberia.
- Akukho kunxibelelana kwaziwayo nokutya.
NGOMLOMO:
- Isifo sentliziyoIimveliso ze-oat eziqulethe i-3.6 gram ye-beta-glucan (ifayibha enyibilikayo) yonke imihla, njengenxalenye yokutya okunamafutha asezantsi, ukutya okune-cholesterol encinci. Ikomityi enesiqingatha (iigram ezingama-40) zeQuaker oatmeal iqulethe 2 iigram ze-beta-glucan; ikomityi enye (30 gram) yee-Cheerios iqulethe igram enye ye-beta-glucan.
- Kuba cholesterol ephezulu: 56-150 iigremu zeemveliso ze-oat ezifana ne-oat bran okanye i-oatmeal, ene-3.6-10 gram ye-beta-glucan (ifayibha enyibilikayo) yonke imihla njengenxalenye yokutya okunamafutha asezantsi. Ikomityi enesiqingatha (iigram ezingama-40) zeQuaker oatmeal iqulethe iigram ezi-2 ze-beta-glucan; ikomityi enye (30 gram) yee-Cheerios iqulethe igram enye ye-beta-glucan.
- Ukwehlisa amanqanaba eswekile yegazi kwizigulana ezinesifo seswekile sesi-2Ukutya okuphezulu kwefayibha njengeemveliso ze-oat ezipheleleyo eziqulathe ukuya kwi-25 yeegramu zefayibha enyibilikayo zisetyenziswa yonke imihla. I-38 gram ye-oat bran okanye i-75 gram ye-oatmeal eyomileyo iqulethe malunga ne-3 gram ye-beta-glucan.
Ukuze ufunde okungakumbi malunga nokubhalwa kweli nqaku, nceda ubone Amayeza endalo aVimba weDatha indlela yokusebenza.
- Hou Q, Li Y, Li L, Cheng G, Sun X, Li S, Tian H. Iziphumo ze-metabolic zokutya i-oats kwizigulana ezinesifo seswekile se-2: Ukuphononongwa ngokuchanekileyo kunye nohlalutyo lweemeta. Izondlo. Ngo-2015; 7: 10369-87. Jonga i-abstract.
- UCapone K, Kirchner F, Klein SL, Tierney NK. Iziphumo ze-colloidal oatmeal topical atopic dermatitis cream kulusu lwe-microbiome kunye nepropathi yokuthintela ulusu. J Iziyobisi iDermatol. Ngo-2020; 19: 524-531. Jonga i-abstract.
- UAndersen JLM, uHansen L, uThomsen BLR, uChristianen LR, uDragsted LO, u-Olsen A. Ngaphambi nangemva kokuxilongwa kokutya okuziinkozo kunye neemveliso zobisi kunye nokuxelwa komhlaza wamabele: Ukutya kwesiDanish, iCancer kunye neqela lezeMpilo. Unyango loMhlaza wamabele. Ngo-2020; 179: 743-753. Jonga i-abstract.
- I-Leão LSCS, i-Aquino LA, iDias JF, iKoifman RJ. Ukongezwa kwe-oat bran kunciphisa i-HDL-C kwaye ayenzi amandla okutya okunekhalori ezisezantsi ekuxolelweni kwesifo se-metabolic syndrome: Isilingo esine-pragmatic, randomized, controlled, open-label. Isondlo. Ngo-2019; 65: 126-130. Jonga i-abstract.
- UZhang T, uZhao T, uZhang Y, et al. Ukongezwa kweActramramide kunciphisa ukuqaqanjelwa kokuzivocavoca okubangelwa kukuzivocavoca kumadoda namabhinqa aselula. J Int Soc yeMidlalo yeZondlo. 2020; 17: 41. Jonga i-abstract.
- Sobhan M, Hojati M, Vafaie SY, Ahmadimoghaddam D, Mohammadi Y, Mehrpooya M.Ukusebenza kwe-colloidal oatmeal cream 1% njengonyango olongezelelekileyo kulawulo lwe-eczema yesandla esinganyangekiyo: Isifundo esingaboni kabini. Iklinikhi yoPhando ngeDermatol. Ngo-2020; 13: 241-251. Jonga i-abstract.
- UAlakoski A, uHervonen K, uMansikka E, et al. Ukhuseleko lwexesha elide kunye nomgangatho weziphumo zobomi be-oats kwi-dermatitis herpetiformis. Izondlo. Ngo-2020; 12: 1060. Jonga i-abstract.
- Spector Cohen I, Day AS, Shaoul R. Ngaba yi-oats okanye ungabi? Uhlaziyo kwingxoxo-mpikiswano eqhubekayo kwii-oats kwizigulana ezinesifo se-celiac. Ngaphambili Pediatr. Ngo-2019; 7: 384. Jonga i-abstract.
- ILyskjær L, Overvad K, Tjønneland A, Dahm CC. Ukutshintshwa kwe-oatmeal kunye nesidlo sakusasa ezinye iindlela zokutya kunye neqondo lokubetha. Ukubetha. Ngo-2020; 51: 75-81. Jonga i-abstract.
- UDelgado G, uKleber ME, uKrämer BK, okqhubekayo. Ungenelelo lokutya kunye ne-oatmeal kwizigulana ezinohlobo olungalawulwayo lwe-2 yeswekile-isifundo se-crossover. Exp Eklinikhi yesifo seswekile. Ngo-2019; 127: 623-629. Jonga i-abstract.
- Ikhowudi yeKhompyuter yeMigaqo yeFederal. Isihloko 21. Icandelo 101. Icandelwana E-IsiGunyaziso esithile seMibango yezeMpilo. Ifumaneka kwi: http://www.ecfr.gov/cgi-bin/text-idx?SID=c7e427855f12554dbc292b4c8a7545a0&mc=true&node=pt21.2.101&rgn=div5#se21.2.101_176. Kufumaneka ngo-Matshi 9, 2020.
- IPridal AA, uBöttger W, uRoss AB. Uhlalutyo lwe-avenanthramides kwiimveliso ze-oat kunye noqikelelo lwe-avenanthramide yokutya ebantwini. Ukutya Chem 2018; 253: 93-100. ikhonkco: 10.1016 / j.foodchem.2018.01.138. Jonga i-abstract.
- I-Kyrø C, i-Tjønneland A, i-Overvad K, i-Olsen A, i-Landberg R. Ukutya okuphezulu okupheleleyo kweNkozo kunxulunyaniswa nomngcipheko osezantsi wohlobo lwe-2 yeswekile phakathi kwamadoda nabasetyhini abaphakathi: Isidlo saseDenmark, uMhlaza kunye neQela lezeMpilo. J Nutrition 2018; 148: 1434-44. ikhonkco: 10.1093 / jn / nxy112. Jonga i-abstract.
- Mackie AR, Bajka BH, Rigby NM, okqhubekayo. Ubungakanani be-Oatmeal ubungakanani bamasuntswana butshintsha isalathiso se-glycemic kodwa hayi njengomsebenzi wenqanaba lokukhupha isisu. NdinguJ Physiol Isisu esiswini sePhysiol. Ngo-2017; 313: G239-G246. Jonga i-abstract.
- U-Li X, u-Cai X, u-Ma X, et al. Iziphumo eziMfutshane kunye nezeXesha elide le-Wholegrain Oat Intake kuLawulo lweSisindo kunye ne-Glucolipid Metabolism kuDidi lwe-2 yeswekile: Uvavanyo olungahleliwe. Izondlo. Ngo-2016; 8. Jonga i-abstract.
- UKennedy DO, uJackson PA, uForster J, et al. Iziphumo ezibi ze-green-oat yasendle (Avena sativa) yokukhupha ekusebenzeni kwengqondo kubantu abadala abaphakathi: Ukulawulwa okungaboniyo kabini, okulawulwa yi-placebo, ngaphakathi-kuvavanyo lwezifundo. Isondlo Neurosci. Ngo-2017; 20: 135-151. Jonga i-abstract.
- Ilnytska O, Kaur S, Chon S, et al. IColloidal Oatmeal (IAvena Sativa) Iphucula umqobo wolusu ngokusebenza kwamayeza amaninzi. J Iziyobisi iDermatol. Ngo-2016; 15: 684-90. Jonga i-abstract.
- UReynertson KA, uGaray M, uNebus J, uChon S, uKaur S, uMahmood K, uKizoulis M, uSouthall MD. Imisebenzi echasene nokuvuvukala kwe-colloidal oatmeal (Avena sativa) inegalelo ekusebenzeni kwe-oats kunyango lwe-itch ehambelana nolusu olomileyo nolucaphukisayo. J Iziyobisi iDermatol. Ngo-2015 uJan; 14: 43-8. Jonga i-abstract.
- UNakhaee S, Nasiri A, Waghei Y, Morshedi J. Thelekisa i-Avena sativa, iviniga, kunye nehydroxyzine ye-uremic pruritus yezigulana ze-hemodialysis: i-crossover ilingo elingenamkhethe. Iran J Izintso Dis. NgoJulayi 2015; 9: 316-22. Jonga i-abstract.
- UKrag A, uMunkholm P, u-Israelsen H, u-von Ryberg B, u-Andersen KK, u-Bendtsen F. Profermin uyasebenza kwizigulana ezine-ulcerative colitis -ilingo elilawulwa ngokungahleliwe. Ukudumba kwesisu Dis. Ngo-2013; 19: 2584-92. Jonga i-abstract.
- Umlingani SG, Tracey EJ. Ukuphazamiseka kwamathumbu amancinci okubangelwa yi-oat-bran bezoar. N Engl J Med 1989; 320: 1148-9. Jonga i-abstract.
- IHendricks KM, iDong KR, iTang AM, et al. Ukutya okunefayibha ephezulu kumadoda ane-HIV kunxulunyaniswa nomngcipheko omncinci wokukhula kokubekwa kwamafutha. NdinguJ J Clin Nutr 2003; 78: 790-5. Jonga i-abstract.
- UStorsrud S, u-Olsson M, u-Arvidsson uLenner R, et al. Abantu abadala abagulayo banganyamezeli izixa ezikhulu zeoats. I-Eur J yeklinikhi yeNutr 2003; 57: 163-9. . Jonga i-abstract.
- UDe Paz Arranz S, uPerez Montero A, uRemon LZ, uMolero MI. Ukuqhagamshelana ne-urticaria kwi-oatmeal. Utywala 2002; 57: 1215. . Jonga i-abstract.
- ULembo A, Camilleri M. Ukuqhina okungapheliyo. N Engl J Med 2003; 349: 1360-8. . Jonga i-abstract.
- IRao SS. Ukuqunjelwa: uvavanyo kunye nonyango. Iklinikhi yaseGastroenterol North Am 2003; 32: 659-83 .. Jonga i-abstract.
- UJenkins DJ, Wesson V, Wolever TM, okqhubekayo. Isonka esipheleleyo kunye nesonka se-wholegrain: inani leenkozo ezipheleleyo okanye eziqhekekileyo kunye nempendulo ye-glycemic. BMJ 1988; 297: 958-60. Jonga i-abstract.
- UTerry P, uLagergren J, nina W, et al. Umanyano oguqukayo phakathi kokutya ifayibha yokutya kunye nomngcipheko wesifo somhlaza esiswini. I-Gastroenterology 2001; 120: 387-91 .. Jonga i-abstract.
- IKerckhoffs DA, Hornstra G, Mensink RP. Ukunciphisa isiphumo se-cholesterol ye-beta-glucan evela kwi-oat bran kwizifundo ezinobumnene ze-hypercholesterolemic kunokuhla xa i-beta-glucan ifakwe kwisonka nakwiicookies. NdinguJ J weNyango yeNyama 2003; 78: 221-7 .. Jonga i-abstract.
- UVan Horn L, uLiu K, uGerber J, okqhubekayo. I-oats kunye ne-soy ekudleni okunciphisa i-lipid kwabasetyhini abane-hypercholesterolemia: ngaba kukho ukusebenzisana? J Nditya i-Assoc 2001; 101: 1319-25. Jonga i-abstract.
- UChandalia M, Garg A, Lutjohann D, et al. Iziphumo eziluncedo zokutya ifayibha ephezulu kwizigulana ezinesifo seswekile seswekile. U-Eng Eng J Med 2000; 342: 1392-8. Jonga i-abstract.
- I-Maier SM, i-Turner ND kunye ne-Lupton JR. I-Serum lipids kwi-hypercholesterolemic yamadoda nabafazi abasebenzisa i-oat bran kunye neemveliso ze-amaranth. Uhlobo lweCereal Chem 2000: 77; 297-302.
- UFoulke J. FDA uvumela konke ukutya kweOat ukwenza ibango lezeMpilo ekunciphiseni umngcipheko weSifo sentliziyo. Iphepha leNtetho le-FDA. 1997. Iyafumaneka kwi: http://www.fda.gov/bbs/topics/ANSWERS/ANS00782.html.
- IBraaten JT, uWood PJ, uScott FW, et al. I-Oat beta-glucan inciphisa uxinzelelo lwe-cholesterol egazini kwizifundo ze-hypercholesterolemic. I-Eur J yezeMpilo ngo-1994; 48: 465-74. Jonga i-abstract.
- UAnderson JW, uGilinsky NH, uDeakins DA, et al. Iimpendulo zeLipid zamadoda e-hypocholesterolemic ukuya kwi-oat-bran kunye nengqolowa ye-bran. NdinguJ oNyango lweeKlinikhi. Ngo-1991; 54: 678-83. Jonga i-abstract.
- UVan Horn LV, uLiu K, uParker D, et al. Impendulo ye-serum lipid kukutya kwemveliso ye-oat kunye nokutya okuguqulweyo okunamafutha. J Ndiyi-Assoc 1986; 86: 759-64. Jonga i-abstract.
- Ukutya kunye noLawulo lweziyobisi. Ilebheli yokutya: amabango ezempilo: i-oats kunye nesifo sentliziyo. Ukubhaliswa kweFed 1996; 61: 296-313.
- U-Lia A, uHallmans G, uSandberg AS, et al. I-Oat beta-glucan yonyusa ukukhutshwa kwe-bile acid kunye neqhekeza elinefayibha elityebileyo elonyusa ukukhutshwa kwe-cholesterol kwizifundo ze-ileostomy. NdinguJ J Clin Nutriti 1995; 62: 1245-51. Jonga i-abstract.
- UBrown L, uRosner B, uWillett WW, uSacks FM. Iziphumo zokunciphisa i-cholesterol kwifayibha yokutya: uhlalutyo lweemeta. NdinguJ J Clin Nutriti 1999; 69: 30-42. Jonga i-abstract.
- URipsen CM, uKeenan JM, uJacobs DR, et al. Iimveliso ze-Oat kunye nokwehla kweepidid. Uhlalutyo lweemeta. IJAMA 1992; 267: 3317-25. Jonga i-abstract.
- UDavidson MH, uDugan LD, uBurns JH, et al. Iziphumo zehypocholesterolemic ze-beta-glucan kwi-oatmeal kunye ne-oat bran. IJAMA 1991; 265: 1833-9. Jonga i-abstract.
- UDwyer JT, uGoldin B, uGorbach S, uPatterson J. Uvavanyo lonyango lweziyobisi: ifayibha yokutya kunye nezongezo zefayibha kunyango lweengxaki zesisu. NdinguJ Hosp Pharm 1978; 35: 278-87. Jonga i-abstract.
- Kritchevsky D.Izinto zokutya kunye nomhlaza. I-Eur J Cancer ngaphambili 1997; 6: 435-41. Jonga i-abstract.
- UAlmy TP, uHowell DA. Inkqubela phambili kwezonyango; Izifo ezahlukeneyo zekholoni. N Engl J Med 1980; 302: 324-31.
- IAlmy TP. Ifayibha kunye namathumbu. NdinguJ Med 1981; 71: 193-5.
- I-Reddy BS. Indima yefayibha yokutya kumhlaza wekolon: ukujonga ngokubanzi. NdinguJ Med 1999; 106: 16S-9S. Jonga i-abstract.
- I-Rosario PG, i-Gerst PH, i-Prakash K, i-Albu E.Ukuchaneka okungafunekiyo: I-oat bran bezoars ibangela ukuphazamiseka. J NdinguGeriatr Soc 1990; 38: 608.
- UArffmann S, uHojgaard L, uGiese B, uKrag E. Iziphumo ze-oat bran kwisalathiso se-lithogenic se-bile kunye ne-bile acid metabolism. Ukwetyisa 1983; 28: 197-200. Jonga i-abstract.
- IBraaten JT, uWood PJ, uScott FW, uRiedel KD, et al. I-oat gum yehlisa iswekile kunye ne-insulin emva komthwalo we-glucose ngomlomo. NdinguJ J weeKlinikhi ngo-1991; 53: 1425-30. Jonga i-abstract.
- IBraaten JT, uScott FW, uWood PJ, et al. I-beta-glucan oat bran ephezulu kunye ne-oat gum zinciphisa i-postprandial yeglucose kunye ne-insulin kwizifundo ezingena-type 2 yeswekile. Iswekile ngo-1994; 11: 312-8. Jonga i-abstract.
- Umthi PJ, uBraaten JT, uScott FW, et al. Iziphumo zedosi kunye notshintsho lweempawu ezibonakalayo ze-oat gum kwi-plasma glucose kunye ne-insulin elandela umthwalo we-glucose yomlomo. Br J Amanqatha 1994; 72: 731-43. Jonga i-abstract.
- Chonga ME, Hawrysh ZJ, Gee MI, et al. Iimveliso zesonka ezigxile kwi-oat bran ziphucula ulawulo lwexesha elide seswekile: isifundo somqhubi. J Nditya i-Assoc 1996; 96: 1254-61. Jonga i-abstract.
- Umlingani SG, Tracey EJ. Ukuphazamiseka kwamathumbu amancinci okubangelwa yi-oat-bran bezoar. N Engl J Med 1989; 320: 1148-9.
- URipsin CM, uKeenan JM, uJacobs DR Jr, et al. Iimveliso ze-Oat kunye nokwehla kweepidid. Uhlalutyo lweemeta. IJAMA 1992; 267: 3317-25. Jonga i-abstract.
- IBraaten JT, uWood PJ, uScott FW, et al. I-Oat beta-glucan inciphisa uxinzelelo lwe-cholesterol egazini kwizifundo ze-hypercholesterolemic. I-Eur J yezeMpilo ngo-1994; 48: 465-74. Jonga i-abstract.
- I-Poulter N, i-Chang CL, uCuff A, okqhubekayo. Iiprofayili zeLipid emva kokusetyenziswa kwemihla ngemihla kweceat esekwe kwi-oat: ityala elilawulwayo le-crossover. NdinguJ J Clin Nutriti 1994; 59: 66-9. Jonga i-abstract.
- UMarlett JA, uHosig KB, uVollendorf NW, et al. Indlela yokunciphisa i-cholesterol ye-serum nge-oat bran. IHepatol 1994; 20: 1450-7. Jonga i-abstract.
- URomero AL, uRomero JE, uGalaviz S, uFernandez ML. Iicookies zityetyiswe nge-psyllium okanye i-oat bran i-plasma esezantsi ye-LDL cholesterol kumadoda aqhelekileyo kunye ne-hypercholesterolemic evela kuMantla eMexico. NdinguColl Nutriti 1998; 17: 601-8. Jonga i-abstract.
- I-Kwiterovich PO Jr. Indima yefayibha kunyango lwe-hypercholesterolemia ebantwaneni nakwishumi elivisayo. Iipedatifikethi 1995; 96: 1005-9. Jonga i-abstract.
- UChen HL, uHaack VS, uJanecky CW, et al. Iindlela apho ingqolowa yengqolowa kunye ne-oat bran zonyusa khona isitulo ebantwini. NdinguJ J Clin Nutr 1998; 68: 711-9. Jonga i-abstract.
- Umbutho weAmerican Dietetic Association. Ifumaneka kwi: www.eatright.org/adap1097.html (Ifumaneka nge-16 kaJulayi 1999).
- UKromhout D, de Lezenne C, Coulander C.Ukutya, ukwanda kunye nokufa kweminyaka eyi-10 kwisifo sentliziyo kwi-871 yamadoda aphakathi. Isifundo seZutphen. NdinguJ Epidemiol 1984; 119: 733-41. Jonga i-abstract.
- UMorris JN, uMarr JW, uClayton DG. Ukutya kunye nentliziyo: okubhaliweyo. Br Med J 1977; 2: 1307-14. Jonga i-abstract.
- I-Khaw KT, iBarrett-Connor E.Ifayibha yokutya kunye nokuncitshiswa kwamanqanaba okusweleka kwesifo sentliziyo kumadoda nabasetyhini: isifundo esinokwenzeka seminyaka eli-12. NdinguJ Epidemiol 1987; 126: 1093-102. Jonga i-abstract.
- Yena J, Klag MJ, Whelton PK, et al. I-oats kunye ne-buckwheat intakes kunye nesifo senhliziyo kunye nemingcipheko yesifo esincinci kwiChina. NdinguJ J Clin Nutriti 1995; 61: 366-72. Jonga i-abstract.
- URimm EB, uAscherio A, uGiovannucci E, et al. Ukuchaneka Imifuno, iziqhamo, kunye nokutya ukutya okune-fiber kunye nomngcipheko wesifo sentliziyo phakathi kwamadoda. IJAMA 1996; 275: 447-51. Jonga i-abstract.
- UVan Horn L. Fibre, lipids, kunye nesifo sentliziyo. Isiteyitimenti sabaqeqeshi bezempilo abasuka kwiKomiti yeZondlo, Am Heart Assn. Ukujikeleza kwe1997; 95: 2701-4. Jonga i-abstract.
- UPietinen P, uRimm EB, uKorhonen P, et al. Ukungeniswa kwefayibha yokutya kunye nomngcipheko wesifo sentliziyo kwi-cohort yamadoda aseFinland. I-alpha-tocopherol, isifundo se-beta-carotene somhlaza. Ukujikeleza kwe1996; 94: 2720-7. Jonga i-abstract.
- IWursch P, iPi-Sunyer FX. Indima yefayibha enyibilikayo ebonakalayo kulawulo lwe-metabolic seswekile. Uphononongo ngokugxininisa ngokukodwa kwiicereal ezityebileyo kwi-beta-glucan. Unonophelo lweSwekile 1997; 20: 1774-80. Jonga i-abstract.
- Iphepha leNtetho le-FDA. I-FDA ivumela konke ukutya kwe-Oat ukwenza iBango ekuNciphiseni umngcipheko weSifo seNtliziyo. 1997. Iyafumaneka kwi: vm.cfsan.fda.gov/~lrd/tpoats.html.
- Ikhowudi yeKhompyuter yeMigaqo yeFederal. Itayitile 21. Icandelo le-182 -Iziyobisi zivunywa ngokubanzi njengezikhuselekileyo. Ifumaneka kwi: https://www.accessdata.fda.gov/script/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=182
- USchatzkin A, uLanza E, uCorle D, et al. Ukunqongophala kwesiphumo sokutya okunamafutha asezantsi, ukutya okunefayibha ephezulu kuphindaphindo lwe-adenomas ebala. Iqela lokuFunda ngokuLinga ukuPhepha kwePolyp. U-Eng Eng J Med 2000; 342: 1149-55. Jonga i-abstract.
- UDavy BM, uMelby CL, uBeske SD, et al. Ukusetyenziswa kwe-oat akuchaphazeli ukuphumla okungafunekiyo kunye nokuhamba koxinzelelo lwegazi lwe-24-h kumadoda anexinzelelo oluphezulu lwegazi ukuya kwinqanaba Ixinzelelo lwegazi. J Nutriti 2002; 132: 394-8 .. Jonga okungafakwanga.
- ILudwig DS, iPereira MA, iKroenke CH, et al. Ifayibha yokutya, ukuzuza ubunzima, kunye nesifo sentliziyo kwizinto ezinobungozi kubantu abadala abancinci. IJAMA 1999; 282: 1539-46. Jonga i-abstract.
- UMcGuffin M, uHobbs C, u-Upton R, uGoldberg A, ii-eds. Incwadana yokhuseleko lwezityalo yaseMelika. IBoca Raton, FL: ICR Press, LLC 1997.